FH-deficient
Showing 1 - 25 of 946
Systemic Treatments in FH-deficient RCC
Recruiting
- Metabolomics
- +3 more
- Sequencing
-
Shanghai, ChinaYunze Xu
Aug 15, 2022
Treatment in FH-deficient RCC Patients
Recruiting
- FH-Deficient RCC
- +2 more
- Laboratory analysis of samples
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Sep 6, 2022
Carcinoma, Renal Cell, Fumarate Hydratase Deficiency, Immunotherapy Trial in Chengdu (Sintilimab injection plus Inlyta
Recruiting
- Carcinoma, Renal Cell
- +2 more
- Sintilimab injection plus Inlyta treatment
-
Chengdu, Sichuan, ChinaWest China Hospital
Jul 11, 2021
Familial Hypercholesterolemia Trial
Not yet recruiting
- Familial Hypercholesterolemia
- (no location specified)
Apr 11, 2023
Familial Hypercholesterolemia, Cholesterol, Elevated, Genetic Disease Trial in Duluth (Motivational interview (MI))
Recruiting
- Familial Hypercholesterolemia
- +2 more
- Motivational interview (MI)
-
Duluth, Minnesota
- +1 more
Feb 1, 2023
Familial Hypercholesterolemia Trial in Philadelphia (Testing centralized referral mechanisms for PCPs, Testing out patient
Active, not recruiting
- Familial Hypercholesterolemia
- Testing centralized referral mechanisms for PCPs
- Testing out patient outreach methods
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
Feb 17, 2023
Cancer, Breast, Cancer, Ovarian, Cancer, Colorectal Trial in Toronto (FHAMe Intervention)
Active, not recruiting
- Cancer, Breast
- +6 more
- FHAMe Intervention
-
Toronto, Ontario, CanadaMount Sinai Hospital
Aug 10, 2022
Metastatic Renal Cell Carcinoma, Fumarate Hydratase Deficient Renal Cell Carcinoma, Succinate Dehydrogenase Deficient Renal Cell
Recruiting
- Metastatic Renal Cell Carcinoma
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Dec 21, 2021
Program With Lipid Screening asMeans to Identify Familial
Enrolling by invitation
- Familial Hyperlipidemia
-
Loveland, ColoradoMedical Center of the Rockies
Mar 2, 2023
Familial Hypercholesterolemia Trial in Nashville (2-Hydroxybenzylamine, Placebo)
Not yet recruiting
- Familial Hypercholesterolemia
- 2-Hydroxybenzylamine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 4, 2022
Familial Hypercholesterolemia, Atherosclerosis Trial (Visualization of coronary Imaging and oral description)
Not yet recruiting
- Familial Hypercholesterolemia
- Atherosclerosis
- Visualization of coronary Imaging and oral description
- (no location specified)
Mar 6, 2023
Lipid Metabolism Disorder Trial (Implementation Strategy Bundle, Usual care notification)
Not yet recruiting
- Lipid Metabolism Disorder
- Implementation Strategy Bundle
- Usual care notification
- (no location specified)
Jan 11, 2023
Familial Hypercholesterolemia Trial in Philadelphia (Cascade screening)
Enrolling by invitation
- Familial Hypercholesterolemia
- Cascade screening
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania, Perelman School of Medicine
Feb 27, 2023
Familial Hypercholesterolemia Trial in Amsterdam (Coronary computed tomography angiography (CCTA))
Recruiting
- Familial Hypercholesterolemia
- Coronary computed tomography angiography (CCTA)
-
Amsterdam, NetherlandsAmsterdam UMC, location AMC
Apr 27, 2022
Hypercholesterolemia, Familial, Hypercholesterolemia, Familial, 1, Hypercholesterolemia, Familial, 2 Trial in Moscow (genetic,
Recruiting
- Hypercholesterolemia, Familial
- +25 more
- Genetic Testing
- +7 more
-
Moscow, Russian FederationNational Medical Research Centre for Therapy and Preventive Medi
Jul 25, 2022
Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Stage IV Pancreatic Cancer AJCC v8
- Autologous Mesothelin-specific TCR-T Cells
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 31, 2023
Cardiovascular Risk Markers in Familial Hypercholesterolemia
Recruiting
- Familial Hypercholesterolemia
-
Oslo, NorwayOslo University Hospital
Oct 12, 2022
Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)
Suspended
- Solid Tumor
- ARID1A Gene Mutation
-
Greenville, South CarolinaPrisma Health Cancer Institute
Jan 10, 2023
Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications Trial in New York (Oral
Not yet recruiting
- Adolescent Idiopathic Scoliosis
- +6 more
- Oral ferrous sulfate
- Oral placebo tablet
-
New York, New YorkColumbia University Medical Center
Sep 12, 2023
Diet-induced Elevations in LDL-C and Progression of
Recruiting
- Hypercholesterolemia
-
Torrance, CaliforniaLundquist Institute for Biomedical Innovation at Harbor UCLA Med
Feb 17, 2023
Familial Hypercholesterolemia Trial (FH diagnosis program, Implementation strategy package: Develop and implement tools for
Not yet recruiting
- Familial Hypercholesterolemia
- FH diagnosis program
- +7 more
- (no location specified)
Mar 8, 2022
Familial Hypercholesterolemia, Familial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein B, Familial
Recruiting
- Familial Hypercholesterolemia
- +7 more
- Research-based genetic test for Familial Hypercholesterolemia
-
Vancouver, British Columbia, Canada
- +1 more
Jan 31, 2022
Guided Bone Regeneration Trial in Cairo (Double layer technique)
Completed
- Guided Bone Regeneration
- Double layer technique
-
Cairo, EgyptAin shams university , faculty of dentistry
Nov 15, 2023
Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Malignant Solid Neoplasm
- Alisertib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022